M&A Deal Summary |
|
|---|---|
| Date | 2024-06-03 |
| Target | North Georgia Clinical Research |
| Sector | Life Science |
| Buyer(s) | Alcanza Clinical Research |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2021 |
| Sector | Life Science |
Alcanza Clinical Research is an integrated network of research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from under-represented communities. Alcanza Clinical Research was founded in 2021 and is based in Lake Mary, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science M&A | 4 of 4 |
| Type: Add-on Acquisition M&A Deals | 6 of 6 |
| State: Georgia M&A | 1 of 1 |
| Country: United States M&A | 5 of 5 |
| Year: 2024 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-05-01 |
KCRI
Kansas , Missouri, United States KCRI specializations focused on gastroenterology, gastrointestinal oncology, hepatology, and a host of metabolic diseases. KCRI is based in Kansas, Missouri. |
Buy | - |
